While we observed this effect may be driven by IL-6 blockade, previous studies in prostate cancer observed elevated numbers of IFN-γ–producing CD4+ T cells upon administration of CTLA-4–blocking Abs. This evidence concerns the gene CTLA4 and Familial prostate cancer.